IL1B and rheumatoid arthritis: This discrepancy of the IL-1 effect between the animal models and RA patients may therefore be due to differences in timing of treatment, with animals treated at very early stages of disease and RA patients at later stages of chronic synovial inflammation, or may instead be due to differences between the cytokine interactions in rodents versus humans [30].